| VALERIEVA, Anna, Maria STAEVSKA, Milos JESENAK, Katarina HRUBISKOVA, Marta SOBOTKOVA, Radana ZACHOVA, Roman HAKL, Sladjana ANDREJEVIC, Tobias SUITER, Vesna GRIVCHEVA-PANOVSKA, Ljerka KARADZA-LAPIC, Daniel SOTERES, Ralph SHAPIRO, Jeffrey RUMBYRT, Raffi TACHDJIAN, Vinay MEHTA, F. Ida HSU and Andrea ZANICHELLI. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. AMSTERDAM: ELSEVIER, 2020, vol. 8, No 2, p. 799-802. ISSN 2213-2198. Available from: https://dx.doi.org/10.1016/j.jaip.2019.08.011. |
Other formats:
BibTeX
LaTeX
RIS
@article{1637706,
author = {Valerieva, Anna and Staevska, Maria and Jesenak, Milos and Hrubiskova, Katarina and Sobotkova, Marta and Zachova, Radana and Hakl, Roman and Andrejevic, Sladjana and Suiter, Tobias and GrivchevaandPanovska, Vesna and KaradzaandLapic, Ljerka and Soteres, Daniel and Shapiro, Ralph and Rumbyrt, Jeffrey and Tachdjian, Raffi and Mehta, Vinay and Hsu, F. Ida and Zanichelli, Andrea},
article_location = {AMSTERDAM},
article_number = {2},
doi = {http://dx.doi.org/10.1016/j.jaip.2019.08.011},
keywords = {C1-INHIBITOR; ATTACKS; DEFICIENCY; EFFICACY},
language = {eng},
issn = {2213-2198},
journal = {JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE},
title = {Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema},
url = {http://dx.doi.org/10.1016/j.jaip.2019.08.011},
volume = {8},
year = {2020}
}
TY - JOUR
ID - 1637706
AU - Valerieva, Anna - Staevska, Maria - Jesenak, Milos - Hrubiskova, Katarina - Sobotkova, Marta - Zachova, Radana - Hakl, Roman - Andrejevic, Sladjana - Suiter, Tobias - Grivcheva-Panovska, Vesna - Karadza-Lapic, Ljerka - Soteres, Daniel - Shapiro, Ralph - Rumbyrt, Jeffrey - Tachdjian, Raffi - Mehta, Vinay - Hsu, F. Ida - Zanichelli, Andrea
PY - 2020
TI - Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema
JF - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
VL - 8
IS - 2
SP - 799-802
EP - 799-802
PB - ELSEVIER
SN - 22132198
KW - C1-INHIBITOR
KW - ATTACKS
KW - DEFICIENCY
KW - EFFICACY
UR - http://dx.doi.org/10.1016/j.jaip.2019.08.011
L2 - http://dx.doi.org/10.1016/j.jaip.2019.08.011
N2 - Hereditary angioedema (HAE), an inherited deficiency offunctional C1 esterase inhibitor (C1-INH), is characterized byrecurrent episodes of disabling and often painful swelling insubcutaneous and/or submucosal tissues.1HAE attacks aregenerally unpredictable, but triggers for an attack can includehaving a dental or medical procedure (eg, surgery), other trauma,or stress. A preemptive management plan for patients under-going these types of situations may reduce the risk of HAE at-tacks. Recommendations include administration of short-termprophylaxis in patients with HAE before invasive medical pro-cedures, especially those involving the upper airways or digestivetract, with C1-INH concentrate typically the medication ofchoice.
ER -
VALERIEVA, Anna, Maria STAEVSKA, Milos JESENAK, Katarina HRUBISKOVA, Marta SOBOTKOVA, Radana ZACHOVA, Roman HAKL, Sladjana ANDREJEVIC, Tobias SUITER, Vesna GRIVCHEVA-PANOVSKA, Ljerka KARADZA-LAPIC, Daniel SOTERES, Ralph SHAPIRO, Jeffrey RUMBYRT, Raffi TACHDJIAN, Vinay MEHTA, F. Ida HSU and Andrea ZANICHELLI. Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema. \textit{JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE}. AMSTERDAM: ELSEVIER, 2020, vol.~8, No~2, p.~799-802. ISSN~2213-2198. Available from: https://dx.doi.org/10.1016/j.jaip.2019.08.011.
|
